DRUG · Mapped RxNorm record
phenelzine sulfate
Normalized identity: phenelzine sulfateView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer
NCT02217709
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
laboratory biomarker analysis
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
questionnaire administration
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedPhenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Recurrent Prostate Cancerunresolved
Stage I Prostate Cancerunresolved
Stage IIA Prostate Cancerunresolved
Stage IIB Prostate Cancerunresolved
Stage III Prostate Cancerunresolved
Interventions
phenelzine sulfateDRUG · verified · RxNorm: phenelzine sulfate
Sponsors & collaborators
University of Southern Californialead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02217709 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.